E-LIB Suche - Ergebnisse für: Ochoa-de-Olza, Maria

1

Dual inhibition of MEK and PI3Kβ/δ–a potential therapeutic ..:

Ruiz de Porras, Vicenç ; Bernat-Peguera, Adrià ; Alcon, Clara...
Frontiers in Pharmacology. 15 (2024) - p. , 2024

2

Prognostic Role of Neutrophil, Monocyte and Platelet to Lym..:

Plaja, Andrea ; Teruel, Iris ; Ochoa-de-Olza, Maria...
International Journal of Molecular Sciences. 24 (2023) 14 - p. 11420 , 2023

Link: https://doi.org/10.3390/..

3

Exploring the Immunogenicity of Noncanonical HLA-I Tumor Li..:

Lozano-Rabella, Maria ; Garcia-Garijo, Andrea ; Palomero, Jara...
Clinical Cancer Research. 29 (2023) 12 - p. 2250-2265 , 2023

Link: https://doi.org/10.1158/..

4

A phase Ib/II study of galunisertib in combination with niv..:

Nadal, Ernest ; Saleh, Mansoor ; Aix, Santiago Ponce...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

5

Low-dose irradiation for reversing immunotherapy resistance..:

Ochoa-de-Olza, Maria ; Bourhis, Jean ; Coukos, George.
Journal for ImmunoTherapy of Cancer. 10 (2022) 7 - p. e004939 , 2022

Link: https://doi.org/10.1136/..

6

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525..:

Schöffski, Patrick ; Tan, Daniel S W ; Martín, Miguel...
Journal for ImmunoTherapy of Cancer. 10 (2022) 2 - p. e003776 , 2022

Link: https://doi.org/10.1136/..

7

Tumor-Associated Microbiome: Where Do We Stand?:

Oliva, Marc ; Mulet-Margalef, Nuria ; Ochoa-De-Olza, Maria...
International Journal of Molecular Sciences. 22 (2021) 3 - p. 1446 , 2021

Link: https://doi.org/10.3390/..

8

Resistance to Antiangiogenic Therapies by Metabolic Symbios..:

Jiménez-Valerio, Gabriela ; Martínez-Lozano, Mar ; Bassani, Nicklas...
Cell Reports. 15 (2016) 6 - p. 1134-1143 , 2016

Link: https://doi.org/10.1016/..

9

A phase Ib/II study of galunisertib in combination with niv..:

Nadal, Ernest ; Saleh, Mansoor ; Aix, Santiago Ponce...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386782/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Exploring the Immunogenicity of Noncanonical HLA-I Tumor Li..:

Lozano-Rabella, Maria ; Garcia-Garijo, Andrea ; Palomero, Jara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261919/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525..:

Schöffski, Patrick ; Tan, Daniel S W ; Martín, Miguel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883259/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Low-dose irradiation for reversing immunotherapy resistance..:

Ochoa-de-Olza, Maria ; Bourhis, Jean ; Coukos, George.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289035/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Tumor-Associated Microbiome: Where Do We Stand?:

Oliva, Marc ; Mulet-Margalef, Nuria ; Ochoa-De-Olza, Maria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867144/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Frequency and characteristics of familial melanoma in Spain..:

Marques-Rodas, I. (Iván) ; Martin-Gonzalez, M. (Manuel) ; Nagore, E. (Eduardo)...
https://hdl.handle.net/10171/38273. , 2015

Link: https://hdl.handle.net/1..

15

Table1_Dual inhibition of MEK and PI3Kβ/δ–a potential thera..:

Vicenç Ruiz de Porras ; Adrià Bernat-Peguera ; Clara Alcon...
doi:10.3389/fphar.2024.1331648.s001. , 2024

Link: https://doi.org/10.3389/..